Literature DB >> 35125773

Pulmonary Embolism as Post-COVID-19 Sequelae: Role of Lung Perfusion Scintigraphy.

Keerti Sitani1, Priyanka Verma1, Ramesh D Rao1, Ashok Chandak1, Ramesh V Asopa1.   

Abstract

We present the case of a 41-year-old male, suspected to have pulmonary thromboembolism with a history of coronavirus disease 2019 (COVID-19) infection 1 month ago. He presented with dyspnea and dry cough for 2 weeks. D-dimer was >776.70 mcg/L. Lung perfusion scan with Tc-99m macroaggregated albumin revealed multiple bilateral segmental perfusion defects with no mass lesion/consolidation on high-resolution computed tomography (CT) of lungs suggestive of pulmonary embolism (PE) present according to perfusion only modified PIOPED II criteria. CT pulmonary angiogram showed a large filling defect in the right pulmonary artery. The case emphasizes the prolonged sequelae following COVID-19 after recovery from the acute phase of the illness. Lung perfusion scintigraphy can play an important role in the screening of such patients who may be at risk for developing PE as post-COVID-19 sequelae. Copyright:
© 2021 Indian Journal of Nuclear Medicine.

Entities:  

Keywords:  Coronavirus disease 2019; lung perfusion scintigraphy; pulmonary embolism

Year:  2021        PMID: 35125773      PMCID: PMC8771057          DOI: 10.4103/ijnm.ijnm_45_21

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that causes a SARS, a characteristic hyperinflammatory response, vascular damage, microangiopathy, angiogenesis, and widespread thrombosis.[1] We present the case of a 41-year-old male with suspected pulmonary embolism (PE) post-COVID-19 infection 1 month ago. The patient was diagnosed with COVlD-19 on the basis of reverse transcription polymerase chain reaction analysis of rhinopharyngeal samples when he had the complaints of fever and dyspnea. He did not require hospital admission for the same. At present, he came with a history of dyspnea and dry cough for 2 weeks. His respiratory rate was 20/min and oxygen saturation 88%. D-dimer was >776.70 mcg/L. With a clinical suspicion of pulmonary thromboembolism, a lung perfusion scan was advised by the referring clinician for screening.[2] Lung perfusion scan [Figure 1] with Tc-99m macroaggregated albumin revealed severely reduced perfusion in the right lung, more prominently in the upper and lower lobe. Multiple wedge-shaped perfusion defects were seen in the left lung. Quantitative analysis of the perfusion scan, right lung (%) – upper zone – 2.3%, middle zone – 18.6%, lower zone – 2.3% (total right lung perfusion % – 23.2%), left lung (%) – upper zone – 22.8%, middle zone – 40.2%, and lower zone – 13.8% (total %–76.8%). There was no mass lesion or consolidation on high-resolution computed tomography (CT) of lungs suggestive of PE present according to perfusion only modified PIOPED II criteria.[3] The CT [Figure 2a] showed few areas of juxtapleural fibrosis, suggestive of postinfective changes. In these cases, V/Q scan may be the first scan to indicate the presence of thromboembolic disease and can be a good screening tool for the same. The patient was started on anticoagulation therapy at the earliest. CT chest with pulmonary angiography [Figure 2b and c] was done which confirmed the diagnosis with a large filling defect noted in the right pulmonary artery and its subsegmental branches. There are few studies showing PE in COVID-19 pneumonia[45] and few case reports of PE as post-COVID-19 sequelae.[678] The case emphasizes the prolonged sequelae following COVID-19 after recovery from the acute phase of the illness. More studies may be required to risk stratify thrombotic the patients and identify the role of thromboprophylaxis for the mild cases of COVID-19. Lung perfusion scintigraphy can play an important role in the screening of such patients who may be at risk for developing PE as post-COVID-19 sequelae.
Figure 1

Tc-99m macroaggregated albumin reveal severely reduced perfusion in the right lung, more prominently in the upper and lower lobes. Multiple wedge-shaped perfusion defects seen in the left lung

Figure 2

(a) High-resolution computed tomography lungs shows juxtapleural fibrosis, suggestive of postinfective changes in the middle lobe of the right lung. (b) (Thin arterial postcontrast pulmonary angiography) - shows a right main pulmonary artery thrombus (arrow) causing a narrowing of the vessels downstream. (c) (CTPA, delayed image)-shows similar findings

Tc-99m macroaggregated albumin reveal severely reduced perfusion in the right lung, more prominently in the upper and lower lobes. Multiple wedge-shaped perfusion defects seen in the left lung (a) High-resolution computed tomography lungs shows juxtapleural fibrosis, suggestive of postinfective changes in the middle lobe of the right lung. (b) (Thin arterial postcontrast pulmonary angiography) - shows a right main pulmonary artery thrombus (arrow) causing a narrowing of the vessels downstream. (c) (CTPA, delayed image)-shows similar findings

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  8 in total

1.  SNM practice guideline for lung scintigraphy 4.0.

Authors:  J Anthony Parker; R Edward Coleman; Erin Grady; Henry D Royal; Barry A Siegel; Michael G Stabin; H Dirk Sostman; Andrew J W Hilson
Journal:  J Nucl Med Technol       Date:  2012-01-26

2.  Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer.

Authors:  P S Wells; D R Anderson; M Rodger; I Stiell; J F Dreyer; D Barnes; M Forgie; G Kovacs; J Ward; M J Kovacs
Journal:  Ann Intern Med       Date:  2001-07-17       Impact factor: 25.391

3.  Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment.

Authors:  Giuseppe Di Tano; Luigi Moschini; Marco Loffi; Sophie Testa; Gian Battista Danzi
Journal:  Eur J Case Rep Intern Med       Date:  2020-06-18

4.  Post COVID-19 sequelae: venous thromboembolism complicated by lower GI bleed.

Authors:  Malini Ashok Kumar; Madhavan Krishnaswamy; Judah Nijas Arul
Journal:  BMJ Case Rep       Date:  2021-01-27

5.  Pulmonary embolism in patients with COVID-19 pneumonia.

Authors:  Florian Bompard; Hippolyte Monnier; Ines Saab; Mickael Tordjman; Hendy Abdoul; Laure Fournier; Olivier Sanchez; Christine Lorut; Guillaume Chassagnon; Marie-Pierre Revel
Journal:  Eur Respir J       Date:  2020-07-30       Impact factor: 16.671

6.  Massive pulmonary embolism following recovery from COVID-19 infection: inflammation, thrombosis and the role of extended thromboprophylaxis.

Authors:  Prakash Vadukul; Deepak S Sharma; Paul Vincent
Journal:  BMJ Case Rep       Date:  2020-09-13

Review 7.  Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review.

Authors:  Yasser Sakr; Manuela Giovini; Marc Leone; Giacinto Pizzilli; Andreas Kortgen; Michael Bauer; Tommaso Tonetti; Gary Duclos; Laurent Zieleskiewicz; Samuel Buschbeck; V Marco Ranieri; Elio Antonucci
Journal:  Ann Intensive Care       Date:  2020-09-16       Impact factor: 6.925

Review 8.  Treatment for COVID-19: An overview.

Authors:  Cristina Stasi; Silvia Fallani; Fabio Voller; Caterina Silvestri
Journal:  Eur J Pharmacol       Date:  2020-10-11       Impact factor: 4.432

  8 in total
  2 in total

Review 1.  Pulmonary Embolism in Post-CoviD-19 Patients, a Literature Review: Red Flag for Increased Awareness?

Authors:  Angeliki Mouzarou; Maria Ioannou; Elena Leonidou; Ioanna Chaziri
Journal:  SN Compr Clin Med       Date:  2022-08-19

2.  Cardiovascular manifestations identified by multi-modality imaging in patients with long COVID.

Authors:  Nobuhiro Murata; Akimasa Yamada; Hidesato Fujito; Naoki Hashimoto; Tetsuro Nagao; Yudai Tanaka; Katsunori Fukumoto; Riku Arai; Yuji Wakamatsu; Yasunari Ebuchi; Masaki Monden; Keisuke Kojima; Kentaro Hayashi; Yasuhiro Gon; Yasuo Okumura
Journal:  Front Cardiovasc Med       Date:  2022-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.